BioSpace News Archive

The Agriculture Improvement Act of 2018, also known as the Farm Bill, which was signed into law on December 20, 2018, provides the first statutory language about plant biostimulants in any federal law.

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is pleased to invite participants from the pharmaceutical and biopharma industries to join its San Diego lunch and learn to discuss cold chain management in clinical trials.

On behalf of its members, the Canadian Association for Long-Term Care (CALTC) is urging all Members of Parliament across the country to help tackle social isolation among seniors.

The Food and Drug Administration (FDA) today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.

Benitec Biopharma (ASX: BLT, NADSAQ: BNTC) (the “Company”), a clinical-stage biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA interference with gene therapy, today announced that BB-401, a gene silencing agent comprised of plasmid DNA which produces a 39-nucleotide antisense RNA with specificity against EGFR, is currently undergoing evaluation in a Phase II clinical trial

IEEE the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity, and Lockheed Martin, a global security and aerospace company, have signed an agreement to work together under the IEEE Corporate Partnership Program

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

-- Drug being evaluated for improved functional outcomes and survival rates for patients resuscitated after a cardiac arrest --

Rocket Pharmaceuticals, Inc. today announces that the Company has been selected for addition to the NASDAQ Biotechnology Index®

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood.